Pfizer’s New Benchmark For New Era: 8% Annual Growth Is Sustainable
Executive Summary
The pharmaceutical industry is entering a period where average annual growth rates are likely to hover at about 8%, Pfizer CEO Hank McKinnell predicted during a Nov. 30 analyst meeting in Groton, Conn
You may also be interested in...
Marginal Profitability Of Mature Products Not What It Used To Be – Pfizer CEO
Unlike in the past, continued marketing expenditure is necessary to sustain growth for relatively mature products, Pfizer CEO Hank McKinnell said June 13
Marginal Profitability Of Mature Products Not What It Used To Be – Pfizer CEO
Unlike in the past, continued marketing expenditure is necessary to sustain growth for relatively mature products, Pfizer CEO Hank McKinnell said June 13
Personalized Medicine Will Not Destroy Blockbuster Model – Pfizer Exec
The move to personalized medicine will not put an end to the pharmaceutical blockbuster model, Pfizer Senior VP-Science & Technology Peter Corr said May 16